CLINIGMA

CLINIGMA® was built on the belief that drug development and regulatory decision-making must consider what patients actually experience and value when taking new treatments.

Specializing in regulatory-compliant in-trial patient interviews, we capture authentic patient voices during clinical trials and translate them into regulatory-grade evidence that strengthens submissions and meets ICH-GCP standards. Operating across 35+ countries with a global network of 300+ Master's and PhD-level researchers, we are trusted by leading pharmaceutical companies as a best-in-class partner for patient-focused drug development. Science is at the core of everything we do—our dedicated scientific team follows rigorous methodologies to produce data that supports labelling claims, regulatory submissions, and payer negotiations.

Our proprietary CLINIGMA® Portal is the first system purpose-built to securely capture patients' own words in real time, with full compliance with ICH-GCP and global data protection standards. And with CLINIGMA® Explorer, patient insights no longer have to wait until the end of a trial—transcripts can be filtered, searched, and compared as they arrive, giving teams a head start on understanding what matters most to patients.